Drug LitigationFDA to Transvaginal Mesh Patients: Beware of Complications

June 18, 2012

The Food and Drug Administration (FDA) has issued clear instructions to medical professionals and patients: beware of complications stemming from a transvaginal mesh surgery. In recent months or years, your stress urinary incontinence (SUI) or pelvic organ prolapse (POP) may have prompted you to undergo a transvaginal mesh operation. Tragically, if you’re like many women, you may now face painful, embarrassing, and worrisome complications as a result.

 

These complications may have given rise to legal issues that you and your family might do well to consider. Fortunately, the attorneys and dedicated professionals at Nachawati Law Group know how to help victims like you. Let us answer your most important legal questions by contacting our team today. With years of experience, we’re prepared to give you the straightforward legal advice you’ve been wishing for. For a free consultation, call us at 1.866.545.8364 or email [email protected] . We’re ready to fight for you!

———

About Nachawati Law Group
Nachawati Law Group represents parties in mass tort litigation, businesses and governmental entities in contingent litigation, and individuals in complex personal injury litigation. For more information, visit contact [email protected] or call 214-890-0711.

https://ntrial.com/ntrial/wp-content/uploads/Nachawati-Law-logo-White-2-160x25.png

©2025 Nachawati Law Group           Terms and Conditions | Privacy Policy